Arctic Bioscience AS (DE:9TD) has released an update.
Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
Siglar AS, associated with Arctic Bioscience’s board chairman, Harald Nordal, has acquired 20,000 shares in the company, enhancing its stake alongside its 50% ownership in Capra Invest AS, which holds a significant share in Arctic Bioscience. The company is noted for its development of HRO350, a promising treatment for psoriasis, and its globally sold ROMEGA® dietary supplements.
For further insights into DE:9TD stock, check out TipRanks’ Stock Analysis page.
